Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Taiwan.
Pediatr Neonatol. 2012 Feb;53(1):4-11. doi: 10.1016/j.pedneo.2011.11.003. Epub 2012 Jan 17.
Kawasaki disease (KD) is an acute multi-system vasculitis syndrome of unknown etiology occurring mostly in infants and children younger than 5 years of age. In developed countries, it is the leading cause of acquired heart disease in children. However, KD remains a mysterious disease. Some viruses potentially causing the condition have been isolated, but the results have not been able to be reproduced. This article reviews and summarizes different aspects of KD and provides updated information on diagnosis and treatment. The supplementary criteria for incomplete presentation of KD patients suggested by the American Heart Association, treatment (including tumor necrosis factor-alpha antagonist, methylprednisolone pulse therapy, statins, plasma exchange, and cytotoxic agents) for those with intravenous immunoglobulin treatment failure, and other experiences are also included in this review.
川崎病(KD)是一种病因不明的急性多系统血管炎综合征,主要发生在 5 岁以下婴幼儿。在发达国家,它是儿童获得性心脏病的主要原因。然而,KD 仍然是一种神秘的疾病。已经分离出一些可能导致这种疾病的病毒,但结果无法重现。本文综述并总结了 KD 的不同方面,并提供了关于诊断和治疗的最新信息。美国心脏协会提出的 KD 患者不完全表现的补充标准、对静脉注射免疫球蛋白治疗失败患者的治疗(包括肿瘤坏死因子-α拮抗剂、甲泼尼龙脉冲疗法、他汀类药物、血浆置换和细胞毒性药物),以及其他经验也包括在本综述中。